Castration Resistant Prostatic Cancer: Clinical Trials

4 trials for Castration Resistant Prostatic Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 terminated, 1 withdrawn. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Recruiting 2, Terminated 1, Withdrawn 1
Phase 21Withdrawn 1

Follow Castration Resistant Prostatic Cancer: new trials by email Literature Review of Castration Resistant Prostatic Cancer trials Research Report on Castration Resistant Prostatic Cancer

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of MGC026 in Participants With Advanced Solid Tumors
MGC026 Dose Escalation, MGC026 Dose for Expansion, Pembrollizumab - Advanced Solid Tumor, Advanced Cancer
Phase 1RecruitingMacroGenics3942024-03-062026-10-28
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
JANX007, Darolutamide - Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Phase 1RecruitingJanux Therapeutics2722022-09-152026-10-29
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
NUV-422, Enzalutamide - Prostate Cancer, Prostatic Cancer
Phase 1 / Phase 2WithdrawnNuvation Bio Inc.2022-09-012022-08-05
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer
Phase 1TerminatedNuvation Bio Inc.822022-03-292025-11-06

Narrower conditions

Prostatic Neoplasms, Castration-Resistant (4)  ·  Prostatic Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Sarcoma (1)  ·  Small Cell Lung Carcinoma (1)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Genital Neoplasms, Male (4)  ·  Male Urogenital Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Prostatic Diseases (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Adnexal Diseases (2)  ·  Breast Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)

Interventions

enzalutamide (2)  ·  darolutamide (1)  ·  olaparib (1)  ·  pembrolizumab (1)

Sponsors

Nuvation Bio Inc. (2)  ·  Janux Therapeutics (1)  ·  MacroGenics (1)

Countries

United States (4)  ·  Australia (3)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Yiyun Dai, MD, PhD (1)